Nutrient availability-driven changes in extracellular matrix biochemical and mechanical properties regulate pancreatic cancer cell biology
Kristof TuraniD, Julien GuillardiD, Marta R. Storl-DesmondiD, Lin ShaniD, Yi-Chia HuangiD, Kevin Muñoz FortiiD, Simon SchwöreriD
Abstract
The extracellular matrix (ECM) provides key biochemical and biomechanical cues that govern fundamental cellular processes, including growth and migration. ECM dysregulation and altered cell-matrix interactions are a driver of cancer progression, exemplified by pancreatic ductal adenocarcinoma (PDAC), where an abnormally dense, collagen-rich, and stiff ECM correlates with poor patient outcomes. The PDAC microenvironment is poorly perfused, resulting in altered nutrient availability, yet how this metabolic stress shapes the ECM and its biological activity remains poorly understood. Herein, we demonstrate that glutamine, a key amino acid depleted in poorly perfused PDAC regions, regulates the biochemical composition, mechanical properties, and biological activity of fibroblast-derived ECM. As glutamine availability increases, fibroblasts shift from producing a basement membrane-like ECM toward an interstitial, mature ECM enriched in fibrillar collagens. The ECM generated under glutamine-rich conditions is stiffer, which limits PDAC cell growth, while simultaneously, the elevated collagen I content promotes migration in a 3D spheroid model. Mechanistically, glutamine-dependent collagen I engages integrin 2 (ITGA2) to activate focal adhesion kinase signaling, driving PDAC cell migration independent of growth. In PDAC patients, glutamine stress inversely correlates with collagen expression in CAFs, with collagen I-ITGA2 as the most enriched ECM receptor interaction pair compared to the normal pancreas. These findings establish nutrient availability as a key regulator of ECM biology and offer new avenues to therapeutically intervene with dysregulated cell-matrix interactions in PDAC.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential modulation of cellular phenotype and drug sensitivity by extracellular matrix proteins in primary and metastatic pancreatic cancer cells
O. H. Usman, S. Kumar, … J. Irianto·Molecular Biology of the CellPeer-reviewed·Dec 1, 2023
- Combined effects of matrix stiffness and obesity-associated signaling directs progressive phenotype in PANC-1 pancreatic cancer cells in vitro
A. E. Jones, J. F. Netto, … Catherine F. Whittington·bioRxiv·Jun 11, 2024
- Collagen remodeling dictates pancreatic cancer bioenergetics and outcome through DDR1 activation or degradation
- Engineered extracellular matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids
B. L. LeSavage, A. E. Gilchrist, … S. C. Heilshorn·bioRxiv·Apr 22, 2022
- The extracellular matrix supports breast cancer cell growth under amino acid starvation by promoting tyrosine catabolism
M. Nazemi, B. Yanes, … E. Rainero·bioRxiv·Jun 9, 2021
- Extracellular Matrix Mechanobiology in Pancreatic Ductal Adenocarcinoma: Correlating In Vivo Patient Magnetic Resonance Elastography with Ex Vivo Tissue Mechanics and Histopathology
Oihane Mitxelena‐Iribarren, Daniela S. Garske, … Amaia Cipitria·bioRxiv·Jun 10, 2026